Ento Labs ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.9% 1.9% 1.9% 1.9% 1.9%  
Bankruptcy risk  18.7% 7.1% 7.5% 9.7% 6.9%  
Credit score (0-100)  8 34 31 24 34  
Credit rating  B BBB BB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  14 0 0 0 0  
Gross profit  -45.7 780 795 73.4 -617  
EBITDA  -45.7 -78.1 -864 -6,434 -8,689  
EBIT  -45.7 -78.1 -864 -6,434 -8,689  
Pre-tax profit (PTP)  -47.8 -80.6 -949.7 -6,392.1 -8,709.7  
Net earnings  -47.8 -10.0 -878.0 -6,392.1 -8,709.7  
Pre-tax profit without non-rec. items  -47.8 -80.6 -950 -6,392 -8,710  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  108 98.5 23,156 16,764 6,908  
Interest-bearing liabilities  15.3 269 401 0.0 0.0  
Balance sheet total (assets)  124 674 24,064 18,297 9,044  

Net Debt  -87.1 -278 -23,498 -17,878 -6,252  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  14 0 0 0 0  
Net sales growth  0.0% -100.0% 0.0% 0.0% 0.0%  
Gross profit  -45.7 780 795 73.4 -617  
Gross profit growth  0.0% 0.0% 1.9% -90.8% 0.0%  
Employees  0 3 4 8 8  
Employee growth %  0.0% 0.0% 33.3% 100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  124 674 24,064 18,297 9,044  
Balance sheet change%  0.0% 443.3% 3,469.4% -24.0% -50.6%  
Added value  -45.7 -78.1 -864.1 -6,434.1 -8,689.5  
Added value %  -336.2% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 -1.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 -3.0 -4.0 -5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  -336.2% 0.0% 0.0% 0.0% 0.0%  
EBIT %  -336.2% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% -10.0% -108.8% -8,761.9% 1,408.8%  
Net Earnings %  -351.5% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  -351.5% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  -351.5% 0.0% 0.0% 0.0% 0.0%  
ROA %  -36.8% -19.6% -7.0% -29.6% -63.5%  
ROI %  -36.9% -31.8% -7.2% -31.1% -73.4%  
ROE %  -44.1% -9.6% -7.6% -32.0% -73.6%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  87.4% 14.6% 96.2% 91.6% 76.4%  
Relative indebtedness %  115.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  -638.3% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  190.6% 356.3% 2,719.5% 277.9% 71.9%  
Gearing %  14.1% 273.1% 1.7% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  27.3% 1.8% 25.6% 62.5% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  7.9 1.1 26.5 11.7 4.0  
Current Ratio  7.9 1.1 26.5 11.7 4.0  
Cash and cash equivalent  102.4 547.3 23,899.3 17,877.9 6,251.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  437.5 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  2.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  912.6% 0.0% 0.0% 0.0% 0.0%  
Net working capital  108.5 60.0 23,117.5 16,457.1 6,348.0  
Net working capital %  797.7% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 -26 -216 -804 -1,086  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 -26 -216 -804 -1,086  
EBIT / employee  0 -26 -216 -804 -1,086  
Net earnings / employee  0 -3 -220 -799 -1,089